Cite

HARVARD Citation

    Halmos, B. et al. (2015). Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer. Oncologist. pp. 1298-1303. [Online]. 
  
Back to record